Pain Management/MSK
Nicolas Sanchez, MD, MS
Integrated IR Resident, PGY-2
Thomas Jefferson University Hospital
Disclosure(s): No financial relationships to disclose
Esika Savsani, BS (she/her/hers)
Medical Student
Sidney Kimmel Medical College
Kristen Bradigan, RN, BSN
Clinical Research Nurse III
Thomas Jefferson University Hospital
Corinne Wessner, MBA, RDMS, RVT
Research Sonographer
Thomas Jefferson University
Andrej Lyshchik, MD, PhD
Professor
Thomas Jefferson Univeristy Hospital
Suzanne Long, MD
musculoskeletal radiologist
Thomas Jefferson University Hospital
LEVON N. NAZARIAN, MD, FACR
Professor of Radiology
Thomas Jefferson University and Hospitals
John R. Eisenbrey, PhD
Associate Professor of Radiology
Thomas Jefferson University
Kevin F. Anton, MD, PhD
Assistant Professor of Radiology
Thomas Jefferson University Hospital
Chronic pain following total knee arthroplasty (TKA) for osteoarthritis (OA) occurs in ~20% of patients {1}. Persistent pain leads to reduced mobility, decreased functionality, increased analgesic usage, and poor quality of life {1}. Genicular artery embolization (GAE) is a transarterial catheter-based therapy targeting chronically inflamed synovium by embolizing hypervascular feeding vessels to decrease inflammation and provide symptomatic relief {2}. GAE is proving efficacious in hemarthrosis and osteoarthritis {3}. This study analyzes the efficacy of GAE in improving pain and quality of life, increasing functionality and mobility, and reducing analgesic use in post-TKA patients with chronic pain.
Materials and Methods:
We present early results of a single-arm pilot trial of 10 patients post-TKA for OA with chronic pain. Patients are evaluated pre-GAE, and 2 weeks, 1 month, 3 months, and 6 months post-GAE. Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Short Form-36 (SF-36), Knee injury and Osteoarthritis Outcome Score (KOOS), and pain medication logs will be used to assess pain, functionality, and quality of life pre- and post-GAE. Patients undergo diagnostic imaging of affected knee(s) pre-treatment and 3 and 6 months post-GAE.
Results:
Early results demonstrate decreased pain sustained across a 3 to 6 month period post-GAE. KOOS outcomes show a steady uptrend in function in activities of daily living (86.9% increase) and sports and recreation (122.2% increase) over a 3 to 6 month period, while WOMAC scores decreased over the same period (45.7% decrease). SF-36 scores exhibit a consistent increase in daily physical functioning over the study period (140% increase). Data collection and patient recruitment is ongoing.
Conclusion:
Preliminary results suggest both functional and subjective benefit after GAE for patients with chronic pain post-TKA. Overall trends demonstrate decreased pain and increased functionality in multiple aspects of daily life. These promising results indicate that GAE in post-TKA patients may offer an efficacious, minimally-invasive intervention for a previously under-treated and challenging patient population.